Global In-Vitro Colorectal Cancer Screening Tests Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global In-Vitro Colorectal Cancer Screening Tests market size will reach 1,302.51 Million USD in 2025 and is projected to reach 1,874.71 Million USD by 2032, with a CAGR of 5.34% (2025-2032). Notably, the China In-Vitro Colorectal Cancer Screening Tests market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
In-vitro colorectal cancer screening tests are diagnostic assays conducted outside the body to detect the presence of colorectal cancer or precancerous conditions. These tests involve the analysis of biological samples such as stool or blood to identify specific markers associated with colorectal abnormalities. Examples of in-vitro colorectal cancer screening tests include fecal occult blood tests (FOBT), which detect hidden blood in the stool, and molecular tests that assess genetic or protein markers indicative of colorectal cancer. These non-invasive screening methods play a crucial role in early cancer detection, allowing for timely intervention and improved outcomes. In-vitro colorectal cancer screening tests are valuable tools for population-based screening programs and are recommended as part of routine healthcare to detect and prevent colorectal cancer, one of the leading causes of cancer-related mortality globally.
The major global suppliers of In-Vitro Colorectal Cancer Screening Tests include Alere(Abbott), Beckman Coulter, Siemens Healthcare, Eiken Chemical, Hitachi Chemical (Kyowa Medex), Clinical Genomics Pty Ltd (Quest Diagnostics), Sysmex, QIAGEN, R-Biopharm, Immunostics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of In-Vitro Colorectal Cancer Screening Tests. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global In-Vitro Colorectal Cancer Screening Tests market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the In-Vitro Colorectal Cancer Screening Tests market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of In-Vitro Colorectal Cancer Screening Tests industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of In-Vitro Colorectal Cancer Screening Tests Include:
Alere(Abbott)
Beckman Coulter
Siemens Healthcare
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
R-Biopharm
Immunostics
In-Vitro Colorectal Cancer Screening Tests Product Segment Include:
Biomarker Tests
Fecal Occult Blood Tests
CRC DNA Screening Tests
In-Vitro Colorectal Cancer Screening Tests Product Application Include:
Hospital and Clinics
Ambulatory
Home Care
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global In-Vitro Colorectal Cancer Screening Tests Industry PESTEL Analysis
Chapter 3: Global In-Vitro Colorectal Cancer Screening Tests Industry Porter's Five Forces Analysis
Chapter 4: Global In-Vitro Colorectal Cancer Screening Tests Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global In-Vitro Colorectal Cancer Screening Tests Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global In-Vitro Colorectal Cancer Screening Tests Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, In-Vitro Colorectal Cancer Screening Tests Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global In-Vitro Colorectal Cancer Screening Tests market size will reach 1,302.51 Million USD in 2025 and is projected to reach 1,874.71 Million USD by 2032, with a CAGR of 5.34% (2025-2032). Notably, the China In-Vitro Colorectal Cancer Screening Tests market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
In-vitro colorectal cancer screening tests are diagnostic assays conducted outside the body to detect the presence of colorectal cancer or precancerous conditions. These tests involve the analysis of biological samples such as stool or blood to identify specific markers associated with colorectal abnormalities. Examples of in-vitro colorectal cancer screening tests include fecal occult blood tests (FOBT), which detect hidden blood in the stool, and molecular tests that assess genetic or protein markers indicative of colorectal cancer. These non-invasive screening methods play a crucial role in early cancer detection, allowing for timely intervention and improved outcomes. In-vitro colorectal cancer screening tests are valuable tools for population-based screening programs and are recommended as part of routine healthcare to detect and prevent colorectal cancer, one of the leading causes of cancer-related mortality globally.
The major global suppliers of In-Vitro Colorectal Cancer Screening Tests include Alere(Abbott), Beckman Coulter, Siemens Healthcare, Eiken Chemical, Hitachi Chemical (Kyowa Medex), Clinical Genomics Pty Ltd (Quest Diagnostics), Sysmex, QIAGEN, R-Biopharm, Immunostics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of In-Vitro Colorectal Cancer Screening Tests. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global In-Vitro Colorectal Cancer Screening Tests market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the In-Vitro Colorectal Cancer Screening Tests market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of In-Vitro Colorectal Cancer Screening Tests industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of In-Vitro Colorectal Cancer Screening Tests Include:
Alere(Abbott)
Beckman Coulter
Siemens Healthcare
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
R-Biopharm
Immunostics
In-Vitro Colorectal Cancer Screening Tests Product Segment Include:
Biomarker Tests
Fecal Occult Blood Tests
CRC DNA Screening Tests
In-Vitro Colorectal Cancer Screening Tests Product Application Include:
Hospital and Clinics
Ambulatory
Home Care
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global In-Vitro Colorectal Cancer Screening Tests Industry PESTEL Analysis
Chapter 3: Global In-Vitro Colorectal Cancer Screening Tests Industry Porter's Five Forces Analysis
Chapter 4: Global In-Vitro Colorectal Cancer Screening Tests Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global In-Vitro Colorectal Cancer Screening Tests Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global In-Vitro Colorectal Cancer Screening Tests Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, In-Vitro Colorectal Cancer Screening Tests Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 In-Vitro Colorectal Cancer Screening Tests Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 In-Vitro Colorectal Cancer Screening Tests Product by Type
- 1.2.1 Biomarker Tests
- 1.2.2 Fecal Occult Blood Tests
- 1.2.3 CRC DNA Screening Tests
- 1.3 In-Vitro Colorectal Cancer Screening Tests Product by Application
- 1.3.1 Hospital and Clinics
- 1.3.2 Ambulatory
- 1.3.3 Home Care
- 1.4 Global In-Vitro Colorectal Cancer Screening Tests Market Size Analysis (2020-2032)
- 1.5 In-Vitro Colorectal Cancer Screening Tests Market Development Status and Trends
- 1.5.1 In-Vitro Colorectal Cancer Screening Tests Industry Development Status Analysis
- 1.5.2 In-Vitro Colorectal Cancer Screening Tests Industry Development Trends Analysis
- 2 In-Vitro Colorectal Cancer Screening Tests Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 In-Vitro Colorectal Cancer Screening Tests Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global In-Vitro Colorectal Cancer Screening Tests Market Analysis by Country
- 4.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue Analysis by Country (2020-2025)
- 4.1.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States In-Vitro Colorectal Cancer Screening Tests Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany In-Vitro Colorectal Cancer Screening Tests Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan In-Vitro Colorectal Cancer Screening Tests Market Revenue and Growth Rate (2020-2032)
- 4.5 China In-Vitro Colorectal Cancer Screening Tests Market Revenue and Growth Rate (2020-2032)
- 4.6 France In-Vitro Colorectal Cancer Screening Tests Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. In-Vitro Colorectal Cancer Screening Tests Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea In-Vitro Colorectal Cancer Screening Tests Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada In-Vitro Colorectal Cancer Screening Tests Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy In-Vitro Colorectal Cancer Screening Tests Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia In-Vitro Colorectal Cancer Screening Tests Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico In-Vitro Colorectal Cancer Screening Tests Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil In-Vitro Colorectal Cancer Screening Tests Market Revenue and Growth Rate (2020-2032)
- 4.14 India In-Vitro Colorectal Cancer Screening Tests Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam In-Vitro Colorectal Cancer Screening Tests Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand In-Vitro Colorectal Cancer Screening Tests Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa In-Vitro Colorectal Cancer Screening Tests Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global In-Vitro Colorectal Cancer Screening Tests Market Revenue by Key Suppliers (2021-2025)
- 5.2 Global In-Vitro Colorectal Cancer Screening Tests Competitive Landscape Analysis and Market Dynamic
- 5.2.1 In-Vitro Colorectal Cancer Screening Tests Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 In-Vitro Colorectal Cancer Screening Tests Market Analysis by Type
- 6.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Alere(Abbott)
- 7.1.1 Alere(Abbott) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 7.1.3 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Beckman Coulter
- 7.2.1 Beckman Coulter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 7.2.3 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Siemens Healthcare
- 7.3.1 Siemens Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 7.3.3 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Eiken Chemical
- 7.4.1 Eiken Chemical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 7.4.3 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Hitachi Chemical (Kyowa Medex)
- 7.5.1 Hitachi Chemical (Kyowa Medex) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 7.5.3 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Clinical Genomics Pty Ltd (Quest Diagnostics)
- 7.6.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 7.6.3 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Sysmex
- 7.7.1 Sysmex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Sysmex In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 7.7.3 Sysmex In-Vitro Colorectal Cancer Screening Tests Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 QIAGEN
- 7.8.1 QIAGEN Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 QIAGEN In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 7.8.3 QIAGEN In-Vitro Colorectal Cancer Screening Tests Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 R-Biopharm
- 7.9.1 R-Biopharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 7.9.3 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Immunostics
- 7.10.1 Immunostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Immunostics In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 7.10.3 Immunostics In-Vitro Colorectal Cancer Screening Tests Market
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
